Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection

Microbiology and Immunology

Volumn 56, Issue 2, 2012, Pages 93-98

  Nakai, Hidetaka ^a   Kawamura, Yoshiki ^a   Sugata, Ken ^a   Sugiyama, Hiroko ^a   Enomoto, Yoshihiko ^a   Asano, Yoshizo ^a,d   Ihira, Masaru ^b   Ohashi, Masahiro ^c   Kato, Tomochika ^c   Yoshikawa, Tetsushi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c Toyokawa Municipal Hospital   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus; Infectious mononucleosis; Real time polymerase chain reaction

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE DURATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FEVER; GENE DOSAGE; HEPATOSPLENOMEGALY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFANT; LABORATORY TEST; LYMPHADENOPATHY; MALE; MICROBIAL ACTIVITY; MICROBIAL KINETICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHARYNGITIS; PRESCHOOL CHILD; PRIMARY INFECTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TONSILLITIS; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS LOAD;

ADOLESCENT; CELLS, CULTURED; CHEMOKINES; CHILD; CHILD, PRESCHOOL; CYTOKINES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE DOSAGE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; KINETICS; LEUKOCYTES, MONONUCLEAR; MALE; VIRAL LOAD;

HUMAN HERPESVIRUS 4;

EID: 84858176937     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00410.x     Document Type: Article

References (23)

1. Gulley M.L., Tang W. Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev 23 : 350-66.
2. Hoshino Y., Kimura H., Kuzushima K., Tsurumi T., Nemoto K., Kikuta A., Nishiyama Y., Kojima S., Matsuyama T., Morishima T. (2000) Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load. Bone Marrow Transplant 26 : 199-201.
3. Leung E., Shenton B.K., Green K., Jackson G., Gould F.K., Yap C., Talbot D. (2004) Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler. Transpl Infect Dis 6 : 156-64.
4. Van Esser J.W., Niesters H.G., Thijsen S.F., Meijer E., Osterhaus A.D., Wolthers K.C., Boucher C.A., Gratama J.W., Budel L.M., Van Der Holt B., Van Loon A.M., Lowenberg B., Verdonck L.F., Cornelissen J.J. (2001) Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation. Br J Haematol 113 : 814-21.
5. Cheng C.C., Chang L.Y., Shao P.L., Lee P.I., Chen J.M., Lu C.Y., Lee C.Y., Huang L.M. (2007) Clinical manifestations and quantitative analysis of virus load in Taiwanese children with Epstein-Barr virus-associated infectious mononucleosis. J Microbiol, Immunol Infect = Wei mian yu gan ran za zhi 40 : 216-21.
6. Kimura H., Morita M., Yabuta Y., Kuzushima K., Kato K., Kojima S., Matsuyama T., Morishima T. (1999) Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37 : 132-6.
7. Leung E., Shenton B.K., Jackson G., Gould F.K., Yap C., Talbot D. (2002) Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. J Immunol Methods 270 : 259-67.
8. Pitetti R.D., Laus S., Wadowsky R.M. (2003) Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children. Pediatr Infect Dis J 22 : 736-9.
9. Berger C., Day P., Meier G., Zingg W., Bossart W., Nadal D. (2001) Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 64 : 505-12.
10. Asano Y., Itakura N., Kajita Y., Suga S., Yoshikawa T., Yazaki T., Ozaki T., Yamanishi K., Takahashi M. (1990) Severity of viremia and clinical findings in children with varicella. J Infect Dis 161 : 1095-8.
11. Asano Y., Nakashima T., Yoshikawa T., Suga S., Yazaki T. (1991) Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum. J Pediatr 118 : 891-5.
12. Balfour H.H., Jr., Holman C.J., Hokanson K.M., Lelonek M.M., Giesbrecht J.E., White D.R., Schmeling D.O., Webb C.H., Cavert W., Wang D.H., Brundage R.C. (2005) A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 192 : 1505-12.
13. Williams H., Macsween K., Mcaulay K., Higgins C., Harrison N., Swerdlow A., Britton K., Crawford D. (2004) Analysis of immune activation and clinical events in acute infectious mononucleosis. J Infect Dis 190 : 63-71.
14. Cameron B., Bharadwaj M., Burrows J., Fazou C., Wakefield D., Hickie I., Ffrench R., Khanna R., Lloyd A. (2006) Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J Infect Dis 193 : 664-71.
15. Williams H., Mcaulay K., Macsween K.F., Gallacher N.J., Higgins C.D., Harrison N., Swerdlow A.J., Crawford D.H. (2005) The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol 129 : 266-74.
16. Corsi M.M., Ruscica M., Passoni D., Scarmozzino M.G., Gulletta E. (2004) High Th1-type cytokine serum levels in patients with infectious mononucleosis. Acta Virol 48 : 263-6.
17. Wright-Browne V., Schnee A.M., Jenkins M.A., Thall P.F., Aggarwal B.B., Talpaz M., Estrov Z. (1998) Serum cytokine levels in infectious mononucleosis at diagnosis and convalescence. Leukemia & lymphoma 30 : 583-9.
18. Helminen M., Lahdenpohja N., Hurme M. (1999) Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis 180 : 496-9.
19. Helminen M.E., Kilpinen S., Virta M., Hurme M. (2001) Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 184 : 777-80.
20. Bogunia-Kubik K., Mlynarczewska A., Jaskula E., Lange A. (2006) The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation. Br J Haematol 132 : 326-32.
21. Weck K.E., Dal Canto A.J., Gould J.D., O'guin A.K., Roth K.A., Saffitz J.E., Speck S.H., Virgin H.W. (1997) Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat Med 3 : 1346-53.
22. Lee K.S., Groshong S.D., Cool C.D., Kleinschmidt-Demasters B.K., Van Dyk L.F. (2009) Murine gammaherpesvirus 68 infection of IFNgamma unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease. Cancer Res 69 : 5481-9.
23. Setsuda J., Teruya-Feldstein J., Harris N.L., Ferry J.A., Sorbara L., Gupta G., Jaffe E.S., Tosato G. (1999) Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. Am J Pathol 155 : 257-65.